Bibliografia UJ CM

1/3
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna, Hussein R. Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum Avezum, Cecilia Bahit, Rafael Diaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David Garcia, Margarida Geraldes, Bernard J. Gersh, Sergey Golitsyn, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John Horowitz, Puneet Mohan, Petr Jansky, Basil S. Lewis, Jose Luis Lopez-Sendon, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin, ARISTOTLE Committees and Investigators.
Apixaban versus warfarin in patients with atrial fibrillation.
New England Journal of Medicine
2011 : Vol. 365, nr 11, s. 981-992, il., bibliogr. 15 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 53.298
2/3
Stuart J. Connolly, A. John Camm, Jonathan L. Halperin Halperin, Campbell Joyner, Marco Alings, John Amerena, Dan Atar, Alvaro Avezum, Per Blomstrom, Martin Borggrefe, Andrzej Budaj, Shih-Ann Chen, Chi Keong Ching, Patrick Commerford, Antonio Dans, Jean-Marc Davy, Etienne Delacretaz, Giuseppe Di Pasquale, Rafael Diaz, Paul Dorian, Greg Flaker, Sergey Golitsyn, Antonio Gonzalez-Hermosillo, Christopher B. Granger, Hein Heidbuchel, Josef Kautzner Kautzner, June Soo Kim, Fernando Lanas, Basil S. Lewis, Jose L. Merino, Carlos Morillo, Jan Murin, Calambur Narasimhan, Ernesto Paolasso, Alexander Parkhomenko, Nicholas S. Peters Peters, Kui-Hian Sim, Martin K. Stiles, Supachai Tanomsup, Lauri Toivonen, Janos Tomcsanyi, Christian Torp-Pedersen, Hung-Fat Tse, Panos Vardas, Dragos Vinereanu, Denis Xavier, Jun Zhu, Jun-Ren Zhu, Lidia Baret-Cormel, Estelle Weinling, Christoph Staiger, Salim Yusuf, Susan Chrolavicius, Rizwan Afzal, Stefan H. Hohnloser, PALLAS Investigators.
Dronedarone in high-risk permanent atrial fibrillation.
New England Journal of Medicine
2011 : Vol. 365, nr 24, s. 2268-2276, il., bibliogr. 24 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 53.298
3/3
Ph. Gabriel Steg, Shamir R. Mehta, J. Wouter Jukema, Gregory Y.H. Lip, C. Michael Gibson, Frantisek Kovar, Petr Kala, Alberto Garcia-Hernandez, Ronny W. Renfurm, Christopher B. Granger, RUBY-1 Investigators.
RUBY-1 : a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
European Heart Journal
2011 : Vol. 32, nr 20, s. 2541-2554, il., bibliogr. 43 poz.
p-ISSN: 0195-668X
AZ
ORG
AIF
IF: 10.478
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ